These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31037274)

  • 1. The Effect of Intranasal Oxytocin on Measures of Social Cognition in Schizophrenia: A Negative Report.
    Lee MR; Wehring HJ; McMahon RP; Liu F; Linthicum J; Buchanan RW; Strauss GP; Rubin LH; Kelly DL
    J Psychiatr Brain Sci; 2019; 4(1):. PubMed ID: 31037274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Oxytocin and Cognitive Behavioral Social Skills Training for Social Function in People With Schizophrenia.
    Buchanan RW; Kelly DL; Strauss GP; Gold JM; Weiner E; Zaranski J; Chen S; Blatt F; Holden J; Granholm E
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):236-243. PubMed ID: 33783399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.
    Lee MR; Wehring HJ; McMahon RP; Linthicum J; Cascella N; Liu F; Bellack A; Buchanan RW; Strauss GP; Contoreggi C; Kelly DL
    Schizophr Res; 2013 Apr; 145(1-3):110-5. PubMed ID: 23415472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
    Jarskog LF; Pedersen CA; Johnson JL; Hamer RM; Rau SW; Elliott T; Penn DL
    Schizophr Res; 2017 Jul; 185():88-95. PubMed ID: 28094169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of single dose intranasal oxytocin on social cognition in schizophrenia.
    Davis MC; Lee J; Horan WP; Clarke AD; McGee MR; Green MF; Marder SR
    Schizophr Res; 2013 Jul; 147(2-3):393-7. PubMed ID: 23676253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin administration enhances controlled social cognition in patients with schizophrenia.
    Woolley JD; Chuang B; Lam O; Lai W; O'Donovan A; Rankin KP; Mathalon DH; Vinogradov S
    Psychoneuroendocrinology; 2014 Sep; 47():116-25. PubMed ID: 25001961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of combined oxytocin and cognitive behavioral social skills training on social cognition in schizophrenia.
    Strauss GP; Granholm E; Holden JL; Ruiz I; Gold JM; Kelly DL; Buchanan RW
    Psychol Med; 2019 Jul; 49(10):1731-1739. PubMed ID: 30180918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia.
    Pedersen CA; Gibson CM; Rau SW; Salimi K; Smedley KL; Casey RL; Leserman J; Jarskog LF; Penn DL
    Schizophr Res; 2011 Oct; 132(1):50-3. PubMed ID: 21840177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial.
    Halverson T; Jarskog LF; Pedersen C; Penn D
    Schizophr Res; 2019 Feb; 204():178-182. PubMed ID: 30243853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot six-week randomized controlled trial of oxytocin on social cognition and social skills in schizophrenia.
    Gibson CM; Penn DL; Smedley KL; Leserman J; Elliott T; Pedersen CA
    Schizophr Res; 2014 Jul; 156(2-3):261-5. PubMed ID: 24799299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intranasal oxytocin on neurocognition in people with schizophrenia: A randomized controlled trial.
    İmamoğlu A; Stiles BJ; Jarskog LF; Pedersen CA; Elliott T; Penn DL
    J Psychiatr Res; 2024 Mar; 171():95-98. PubMed ID: 38262165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial.
    Anagnostou E; Soorya L; Chaplin W; Bartz J; Halpern D; Wasserman S; Wang AT; Pepa L; Tanel N; Kushki A; Hollander E
    Mol Autism; 2012 Dec; 3(1):16. PubMed ID: 23216716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.
    Lee MR; Wehring HJ; McMahon RP; Liu F; Linthicum J; Verbalis JG; Buchanan RW; Strauss GP; Rubin LH; Kelly DL
    Schizophr Res; 2016 Apr; 172(1-3):165-8. PubMed ID: 26879587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia.
    Guastella AJ; Ward PB; Hickie IB; Shahrestani S; Hodge MA; Scott EM; Langdon R
    Schizophr Res; 2015 Nov; 168(3):628-33. PubMed ID: 26150070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin to modulate emotional processing in schizophrenia: A randomized, double-blind, cross-over clinical trial.
    Brambilla M; Cotelli M; Manenti R; Dagani J; Sisti D; Rocchi M; Balestrieri M; Pini S; Raimondi S; Saviotti FM; Scocco P; de Girolamo G
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1619-28. PubMed ID: 27527256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth.
    Anagnostou E; Soorya L; Brian J; Dupuis A; Mankad D; Smile S; Jacob S
    Brain Res; 2014 Sep; 1580():188-98. PubMed ID: 24508578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial.
    Quintana DS; Westlye LT; Hope S; Nærland T; Elvsåshagen T; Dørum E; Rustan Ø; Valstad M; Rezvaya L; Lishaugen H; Stensønes E; Yaqub S; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
    Transl Psychiatry; 2017 May; 7(5):e1136. PubMed ID: 28534875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Zhu XM; Zhang QE; Yang XH; Cai DB; Li L; Li XB; Ng CH; Ungvari GS; Ning YP; Xiang YT
    Schizophr Res; 2019 Apr; 206():13-20. PubMed ID: 30573406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin administration selectively improves olfactory detection thresholds for lyral in patients with schizophrenia.
    Woolley JD; Lam O; Chuang B; Ford JM; Mathalon DH; Vinogradov S
    Psychoneuroendocrinology; 2015 Mar; 53():217-22. PubMed ID: 25637811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do we need oxytocin to treat schizophrenia? A randomized clinical trial.
    Dagani J; Sisti D; Abelli M; Di Paolo L; Pini S; Raimondi S; Rocchi MB; Saviotti FM; Scocco P; Totaro S; Balestrieri M; de Girolamo G
    Schizophr Res; 2016 Apr; 172(1-3):158-64. PubMed ID: 26883950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.